Electronic Clinical Outcome Assessment (eCOA) Solutions Market By Delivery Mode (On-premise, and Web

According to Business Intelligence Insights (BII) study, the global Electronic Clinical Outcome Assessment (eCOA) Solutions Market attained revenue growth of USD 1,182.5 million in 2021 and it is projected to reach around USD 3,349.5 million by 2030, growing at a 13.9% CAGR.

Regional Analysis:

North America dominated the market with more than 40% of the market share

The market for electronic clinical outcome assessment solutions (eCOA) in North America is expected to develop rapidly due to an increase in clinical studies. Clinical trials are increasingly growing in the United States and Canada as the demand for drug research grows. Furthermore, ongoing improvements in eCOA methods and strategic alliances among leading market participants are contributing to the country's increased demand for these solutions. The United States obtained the largest revenue share of the market in North America. This is due to the widespread use of healthcare analytics services. Governments and non-profit groups are launching numerous projects to promote the use of eClinical platforms, which increases demand for these solutions.

Segmentation Insights:

By Type:

• Web & Cloud-based categories dominated the market with a major share of the market share
• CROs category dominated the market with a major share of the market share

Web & Cloud-based categories dominated the market with a major share of the market share

Cloud-based solutions are relatively newer approaches that are largely adopted by enterprises that lack the necessary internal infrastructure. These programs are less expensive to install than other systems. Furthermore, these products eliminate the need for in-house maintenance, which is most likely the primary factor driving their increased demand. Because all information (study protocols, patient data, outcomes, etc.) is stored in a central location and maintained by a third-party service provider, cloud-based systems are ideal for complex, multi-site clinical studies. Increasing the use of these platforms by pharmaceutical corporations and contract research organizations is propelling the segment.

By End-User

• CROs
• Hospitals/Healthcare providers
• Pharmaceutical and Biotechnology Firms
• Medical Device Companies
• Others

CROs

Contract Research Organizations (CROs) held the largest revenue share in 2021 and are expected to witness significant growth in the near future due to the outsourcing of clinical research management by major biopharmaceutical and medical device companies. IQVIA eCOA for example supports real-time patient data collection in real-world studies and clinical research. During the COVID-19 the solution was deployed across several trials to enable real-time data capture, cost-effectively, and remotely.

Top Key Players Analysis:

• IBM
• IQVIA Inc.
• Medidata SolutionsInc.
• Clario; ArisGlobal
• Signant Health
• TransPerfect
• Cloudbyz
• Climedo Health GmbH
• ClinCapture

Read our strategic analysis: https://www.businessintelligence-insights.com/reports/71/electronic-clinical-outcome-assessment-ecoa-solutions-market

Business Intelligence Insights is the global provider of market intelligence, consultancy services, and syndicated & customized reports. We are focused on assisting business leaders and suppliers in making decisions